Arcturus Therapeutics Holdings Inc (ARCT)
27.64
-2.49
(-8.26%)
USD |
NASDAQ |
Apr 17, 16:00
27.64
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash and Short Term Investments (Quarterly): 292.00M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 292.00M |
| September 30, 2023 | 311.92M |
| June 30, 2023 | 323.47M |
| March 31, 2023 | 327.94M |
| December 31, 2022 | 391.88M |
| September 30, 2022 | 237.68M |
| June 30, 2022 | 283.49M |
| March 31, 2022 | 319.68M |
| December 31, 2021 | 370.49M |
| September 30, 2021 | 413.88M |
| June 30, 2021 | 433.57M |
| March 31, 2021 | 466.84M |
| December 31, 2020 | 462.90M |
| September 30, 2020 | 307.02M |
| June 30, 2020 | 136.11M |
| March 31, 2020 | 59.47M |
| December 31, 2019 | 71.35M |
| September 30, 2019 | 74.17M |
| June 30, 2019 | 55.84M |
| March 31, 2019 | 31.22M |
| December 31, 2018 | 36.71M |
| Date | Value |
|---|---|
| September 30, 2018 | 32.83M |
| June 30, 2018 | 39.78M |
| December 31, 2017 | 48.57M |
| September 30, 2017 | 39.82M |
| June 30, 2017 | 41.19M |
| March 31, 2017 | 45.25M |
| December 31, 2016 | 8.345M |
| September 30, 2016 | 51.35M |
| June 30, 2016 | 53.08M |
| March 31, 2016 | 53.23M |
| December 31, 2015 | 50.68M |
| September 30, 2015 | 35.51M |
| June 30, 2015 | 41.09M |
| December 31, 2014 | 21.70M |
| September 30, 2014 | 29.44M |
| June 30, 2014 | 38.94M |
| March 31, 2014 | 44.42M |
| December 31, 2013 | 50.10M |
| September 30, 2013 | 19.54M |
| June 30, 2013 | 21.59M |
| December 31, 2012 | 0.097M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
55.84M
Minimum
Jun 2019
466.84M
Maximum
Mar 2021
281.04M
Average
311.92M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Electromed Inc | 10.43M |
| Armata Pharmaceuticals Inc | 13.52M |